Mitotane cytotoxicity chemotherapy cell lines multidrug resistance gene adrenocortical carcinomas P-Glycoprotein Pgp product gene plasma membrane phosphoglycoprotein multidrug resistance cell culture efflux natural product chemotherapeutic agents High levels expression normal adrenal adrenocortical cancers RNA situ hybridization expression adrenocortical cancer present study decreased drug accumulation achievable concentrations mitotane p'-DDD increase drug accumulation addition mitotane due part decrease drug efflux results increase cytotoxicity agents natural product class effect cells broad range expression levels comparable adrenocortical cancers Similar increases drug accumulation unselected adrenocortical cancer cell line finding resistance mitotane rational basis use mitotane combination natural product chemotherapeutic agents adrenocortical cancer 